(Reuters Health) - Just a 5 percent decline in measles vaccination rates could triple the number of young children who get infected with the virus in the U.S., according to a study highlighting the risks of parents refusing to vaccinate their kids.
- Dozens of U.S. clinics sell unproven stem cell therapies for heart failure
- Trump pleads with Republicans to roll back Obamacare |
- U.S. jury finds AbbVie liable for misrepresentation in AndroGel verdict
- Stopping cholesterol-lowering drugs could be deadly
- Merck immunotherapy fails to improve survival in head and neck cancer
COLOMBO An outbreak of dengue virus has killed around 300 people so far this year in Sri Lanka and hospitals are stretched to capacity, health officials said on Monday.
LONDON Three decades after approval of the first-ever AIDS treatment, HIV medicine is seeing a new wave of innovation with scientists reporting positive data on Monday for improved drug cocktails and a novel experimental vaccine.
NEW YORK/SEOUL Merck & Co and South Korea's Samsung Bioepis Co Ltd said on Monday they have begun selling a less expensive alternative version of Johnson & Johnson's rheumatoid arthritis drug Remicade in the United States, a move that should accelerate price declines for the big-selling medicine.
(Reuters Health) - People living in homes with water damage, damp floors or visible mold are more likely to have chronic sinus problems and bronchitis, as well as allergies, asthma and other breathing disorders, according to a large study from Sweden.